Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Isoquinoline Salt. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103724264A details iridium-catalyzed asymmetric hydrogenation for high-purity chiral tetrahydroisoquinoline derivatives, offering significant cost reduction and supply chain reliability.
Patent CN104177357B details a Rh-catalyzed isoquinoline salt synthesis using oxygen. This method offers high purity, cost reduction, and scalable manufacturing for pharmaceutical intermediates.